ArticleViruses2022

FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections.

Robert Meineke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.